脑增殖性血管病:影像谱系与诊断洞见
本文综合复习75项已发表研究、共153例患者的资料,总结脑增殖性血管病(CPA)的完整影像谱系。CPA多见于青少年或青年,女性略多,好发于幕上多脑叶,CT/MRI显示弥漫皮层流空影和匍行强化血管,灌注与代谢成像示广泛低灌注和脑血管储备受损,DSA示无优势供血动脉、近端动脉狭窄和常见硬脑膜侧支。多模态影像对与动静脉畸形鉴别至关重要。
要点
- CPA表现为弥漫血管网与正常脑实质混杂,无紧凑畸形团或优势供血动脉,可有硬脑膜供血。
- CT/MRI见分散皮层流空影和匍行强化血管通道,可伴缺血、皮层萎缩、钙化、出血。
- 灌注与代谢成像显示广泛低灌注和脑血管储备受损,支持缺血驱动发病机制。
核心结论
- CPA是一种少见的脑血管畸形,与经典动静脉畸形有本质区别,多模态影像对鉴别诊断至关重要;标准化报告框架可能有助于完善诊断标准并改善临床结局。
研究设计与样本
- 对75项已发表研究、共153例患者的综合复习。
关键影像表现/征象
- CPA多累及幕上脑多脑叶,CT和MRI典型表现为分散皮层流空影和匍行强化血管通道。
- 继发表现包括缺血、皮层萎缩、钙化、出血及多变静脉引流模式。
- 灌注与代谢成像一致显示广泛低灌注和脑血管储备受损。
- DSA示无优势供血动脉、近端动脉狭窄、常见硬脑膜侧支、罕见血流相关动脉瘤、静脉轻度扩大。
临床应用与阅片要点
- 多模态影像对区分CPA与动静脉畸形及其他类似病变至关重要,因两者处理方式差异很大。
- CPA可呈进展性,有迟发性梗死、出血和神经功能缺损风险。
- 作者认为标准化报告框架可能有助于完善诊断标准并改善临床结局。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Cerebral proliferative angiopathy (CPA) is a rare cerebrovascular malformation that differs fundamentally from classic arteriovenous malformations (AVMs). Unlike AVMs, CPA is characterized by a diffuse vascular network intermingled with normal brain parenchyma, absence of a compact nidus or dominant feeders, and transdural supply. We conducted a comprehensive review of 75 published studies comprising 153 patients to summarize the full imaging spectrum. CPA most commonly presents in adolescence or young adulthood, with a slight female predominance, and generally involves the supratentorial brain, spanning multiple lobes. On CT and MRI, CPA typically demonstrates dispersed cortical flow voids and serpiginous enhancing vascular channels, with secondary findings like ischemia, cortical atrophy, calcifications, hemorrhage, and variable venous drainage patterns. Perfusion and metabolic imaging consistently reveal widespread hypoperfusion and impaired cerebrovascular reserve, supporting its ischemia-driven pathogenesis. DSA shows an absence of dominant feeders, proximal arterial stenoses, frequent transdural collaterals, rarely flow-related aneurysms, and modest venous enlargement. It can occasionally have a progressive nature, with risks of delayed infarction, hemorrhage, and neurologic deficits. Multimodal imaging is essential for distinguishing this under-recognized yet clinically important entity from AVMs and other mimics, because management differs substantially. A standardized reporting framework may help refine diagnostic criteria and improve clinical outcomes.
引用
- Rai P, Chan VEY, Lakhani DA, et al. Cerebral Proliferative Angiopathy: Imaging Spectrum and Diagnostic Insights. AJNR Am J Neuroradiol. 2026. PMID: 41326231. doi:10.3174/ajnr.A9122
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。